SC&H Capital Advises Glenridge HealthCare Solutions in Sale to WhiteGlove Health, Inc.
Baltimore, MD (PRWEB) June 25, 2014 -- SC&H Capital, an investment banking and advisory firm focused on middle market and growth companies, served as the exclusive financial advisor to Glenridge HealthCare Solutions, Inc. (“Glenridge” or “the Company”) in its sale to WhiteGlove Health, Inc., (“WGH”) a portfolio company of private-equity firms Biomark Capital and Enhanced Equity Funds (“EEF”), based in San Francisco and New York city respectively.
Based in Columbia, Maryland, Glenridge is the premier provider of technology-enabled network development and provider engagement solutions to health plans and health systems throughout the United States.
WGH, headquartered in Austin, Texas, is a leading mobile healthcare provider that is focused on both treating the individual and achieving improved overall health and well-being of populations. WGH’s care model includes primary and acute care services; supporting individuals with chronic conditions and focusing on preventable and avoidable care by ensuring patients receive appropriate care after discharge from acute-care hospital facilities.
Through combined operations with Glenridge, WGH will have access to both proprietary analytic tools and unmatched network development capabilities to effectively manage the challenges facing the healthcare industry. Through its relationship with WGH, Glenridge will be able to further expand its impressive customer base and service offerings, and augment its impressive growth trajectory, by leveraging WGH’s extensive network of industry relationships and proven expertise. Glenridge now has access to a superior health care services delivery platform that can assist its clients achieve their population health objectives.
“This deal further broadens our offerings, and enables us to advance our healthcare solutions to a wider audience,” said Terry Spoleti, President, Glenridge HealthCare Solutions, Inc. “Thanks to the encouragement, tenacity, and constant support of the SC&H Capital team, we received the guidance needed to make this deal come to life.”
“We were pleased to be the trusted advisor on a transaction that will fuel additional growth of the most innovative consulting and technology in the healthcare arena,” said Christopher Helmrath, Managing Director, SC&H Capital. “This deal is a prime example of how new provider engagement solutions can be integrated with care services, which will ultimately advance patient outcomes in the long run.”
Financial terms of the investment were not disclosed. Glenridge was advised on legal matters in the transaction by Saul Ewing, LLP.
About Enhanced Equity Funds
Founded in 2005, EEF manages approximately $600 million of committed capital across two funds with the most recent raised in 2010. The Principals of EEF have over 100 years of combined experience investing in healthcare companies and possess strong relationships and knowledge within the industry. They specialize in working with smaller companies (typically less than $100 million in revenue) and take a creative approach to building value. EEF employs a flexible but disciplined investment strategy focused on value creation through organizational development, organic growth and acquisitions.
About Biomark Capital
Biomark Capital provides venture funding and assistance to mid- to late-stage life science and healthcare companies focused on novel approaches to diagnostics, therapeutics, medical devices, and the use of digital health technologies. We share the drive and vision of our portfolio companies to collaborate with them in accelerating growth and building successful business ventures. Biomark Capital has over 50 years of combined venture capital management experience and $200M under management.
About SC&H Capital
SC&H Capital, an affiliate of SC&H Group, LLC, is an investment banking and advisory firm focused on middle market and growth companies. SC&H Capital supports their investment banking activity with a full suite of strategic and financial resources to assist companies in the development and execution of strategic plans and initiatives. In conjunction with SC&H Group, LLC, SC&H Capital tailors their advisory services to ensure that their clients receive pertinent and valuable advice in every stage of the business life cycle – not just at the time of sale.
Securities offered through Stout Causey Capital Corporation, member FINRA/SIPC.
Matt Langan, L&R Communications, +1 202-262-3340, [email protected]
Share this article